Post

Jolanda de Vries joins scientific advisory board of CiMaas

As of October 1, 2020 esteemed tumor immunologist Prof Dr Jolanda de Vries becomes a member of the scientific advisory board.  Jolanda de Vries is head of the department of Tumor Immunology at Radboudumc, Nijmegen, the Netherlands.

Post

CiMaas and the INsTRuCT Consortium receive EU subsidy to train young scientists in developing novel cell therapies

Cell therapy is an active area of immunological research and represents a highly innovative and rapidly expanding sector of the pharmaceutical industry. CiMaas is part of the the INsTRuCT Consortium (www.instruct-h2020.eu) which comprises 15 different European companies or universities from 8 Member States, that answers an unmet need for postdoctoral researchers trained in scientifically excellent… Read more »

Post

CiMaas is featured in “How it’s done” by RTL-Z

On Saturday January 11, 2020, CiMaas appeared in a special program on new innovations in medicine. It is part of a production for the RTL-Z program ” How it’s done”. Broadcast time is 17.00. Saturday April 11 at 16.30; April 14 at 10:30 uur and April 16 at 16:30 the programme will be repeated

Post

Neuroplast and CiMaas join forces

Neuroplast and CiMaas, developers and producers of regenerative cell therapies, are setting up joint shop at the Brightlands Chemelot Campus in Geleen where they will be sharing a new laboratory and office space. Both companies currently employ around 30 people and expect to experience substantial growth.

Post

CiMaas featured in Brightlands media campaign

The national campaign – to the end of June 2019 – airs radiospots and runs advertisements in several national newspapers to draw attention to the collaboration between the University and Brightlands in developing solutions for important societal issues. CiMaas regenerates the immune system to fight cancer.